Search

Search Results

• CO073 | THROMBIN GENERATION PROFILE IN ELDERLY PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF ORAL ANTICOAGULANT TYPE M. Di Gioia¹, M. Berteotti^1|2, G. Ciarrocca Taranta², F. Alfano^1|2, F. Crudele¹, F. Cesari¹, A.M. Gori^1|2, A. Rogolino¹, B. Giusti^1|2, R. Marcucci^1|2 | ¹Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy; ²Dep. of Experimental and Clinical Medicine, University of Florence, Italy

  Michela Di Gioia

  26-10-2026

  https://doi.org/10.4081/btvb.2026.775

  0

  PDF: 0

• PO144 | KIV2 LPA POLYMORPHISM: ROLE IN BAV CLINICAL COMPLICATIONS ACCORDING TO DIFFERENT CLINICAL SETTINGS P. Cantini¹, E. Sticchi¹, G. Barbieri¹, R. Orsi¹, A. Kura¹, F. Basso¹, A. Rogolino¹, M. Berteotti¹, S. Nistri², P. Stefàno³, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Dep. of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Firenze, Italy; ²Cardiology Service CMSR Veneto Medica Altavilla Vicentina, Vicenza, Italy; ³Cardiac Surgery Unit, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Firenze, Italy

  Pietro Cantini

  26-10-2026

  https://doi.org/10.4081/btvb.2026.960

  0

  PDF: 0

• CO070 | PLASMIN GENERATION AND ITS INTERPLAY WITH COAGULATION AND FIBRINOLYSIS IN ATRIAL FIBRILLATION: IMPACT OF ANTICOAGULANT THERAPY G. Ciarrocca Taranta¹, F. Alfano¹, M. Di Gioia², M. Berteotti^1|2, E. Lotti², F. Cesari², A. Rogolino², F.A. Barbuto¹, A. M Gori^1|2, E. Sticchi^1|2, B. Giusti^1|2, R. Marcucci^1|2 | ¹Dep of Experimental and Clinical Medicine, University of Florence, Italy; ²Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Giulia Ciarrocca Taranta

  26-10-2026

  https://doi.org/10.4081/btvb.2026.772

  0

  PDF: 0

• PO134 | FAMILIAL HYPERCHOLESTEROLEMIA 57-GENE PANEL MUTATIONAL ANALYSIS: INSIGHT INTO CARDIOVASCULAR RISK GENETIC PREDISPOSITION A. Kura¹, E. Sticchi¹, G. Barbieri¹, F. Basso¹, P. Cantini¹, S. Suraci¹, M. Berteotti¹, E. Lotti¹, F. Crudele¹, G.M. Scaturro², A. Rogolino¹, A.M. Gori¹, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence - Careggi Hospital, Firenze, Italy; ²Meyer Children's Hospital IRCCS, Metabolic and Neuromuscular Unit, Firenze, Italy

  Ada Kura

  26-10-2026

  https://doi.org/10.4081/btvb.2026.950

  0

  PDF: 0

• CO060 | LP(a) AND CARDIOVASCULAR RISK IN FAMILIAL HYPERCHOLESTEROLEMIA F. Basso¹, G. Barbieri¹, E. Sticchi¹, A. Kura¹, P. Cantini¹, S. Suraci¹, M. Berteotti¹, E. Lotti¹, F. Crudele¹, G.M. Scaturro², A. Rogolino¹, A.M. Gori¹, R. Marcucci¹, B. Giusti¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence, Careggi Hospital, Firenze, Italy; ²Meyer Children's Hospital IRCCS, Metabolic and Neuromuscular Unit, Firenze, Italy

  Francesca Basso

  26-10-2026

  https://doi.org/10.4081/btvb.2026.762

  0

  PDF: 0

• PO057 | IS PLATELET FUNCTION TESTING CLINICALLY USEFUL IN PATIENTS WITH CHRONIC SUBDURAL HEMATOMA UNDERGOING NEUROSURGERY WHILE ON ANTIPLATELET THERAPY? G. Ciarrocca Taranta¹, G. Pansini², S. Orlandini², O. Para³, M. Di Gioia⁴, A. Rogolino⁴, G. Barbieri¹, R. Marcucci^1|4, A. Della Puppa² | ¹Dep of Experimental and Clinical Medicine, University of Florence, Italy; ²Neurosurgical Dep, Careggi University Hospital, Firenze, Italy; ³Internal Medicine 1 Careggi University Hospital, Firenze, Italy; ⁴Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Giulia Ciarrocca Taranta

  26-10-2026

  https://doi.org/10.4081/btvb.2026.873

  0

  PDF: 0

• CO045 | BEYOND THE VISIBLE: LIPOPROTEIN(a) AS A SILENT DRIVER OF RETINAL VASCULAR DAMAGE L. Agrelli¹, M. Berteotti², E. Lotti², F. Crudele², D. Poli², A.M. Gori², A Rogolino², D. Prisco², R. Marcucci² | ¹Department of Internal Medicine, University of Salerno, Italy; ²Department of Medical and Surgical Critical Care, Thrombosis Centre, University of Florence, AOU Careggi, Firenze, Italy

  Lucia Agrelli

  26-10-2026

  https://doi.org/10.4081/btvb.2026.747

  0

  PDF: 0

• PO050 | HEMOSTATIC AND FIBRINOLYTIC PROFILES IN PATIENTS UNDERGOING TAVI: PRELIMINARY RESULTS ON HOMOCYSTEINE, D-DIMER, AND CLOT LYSIS TIME V. Scheggi¹, A. Bertelli², F. Cesari³, A. Rogolino³, G. Ciarrocca Taranta², M. Di Gioia³, G. Barbieri², A.M. Gori^2|3, R. Marcucci^2|3 | ¹Dep of Cardiothoracovascular Medicine, Careggi University Hospital, Firenze, Italy; ²Dep of Experimental and Clinical Medicine, University of Florence, Italy; ³Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Giulia Ciarrocca Taranta

  26-10-2026

  https://doi.org/10.4081/btvb.2026.866

  0

  PDF: 0

• CO024 | THE ROLE OF BLOOD CLOTTING AND ENDOTHELIAL ACTIVATION IN THE STRATIFICATION OF BLEEDING AND THROMBOTIC RISK OF ATRIAL FIBRILLATION ON ORAL ANTICOAGULANT THERAPY: INSIGHTS FROM THE STRAT-AF 2 STUDY F. Alfano^1|2, AM. Gori^1|2, A. Bertelli¹, G. Ciarrocca Taranta¹, M. Di Gioia², F. Cesari¹, A. Rogolino¹, A. Sorrentino¹, B. Giusti^1|2, R. Marcucci^1|2 | ¹Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; ²Center for Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy

  Francesco Alfano

  26-10-2026

  https://doi.org/10.4081/btvb.2026.726

  0

  PDF: 0

• CO099 | OPTIMIZING CUT-OFFS FOR LUPUS ANTICOAGULANT TESTING: EVIDENCE FROM A MULTICENTER REGIONAL STUDY S. Nannini¹, G. Andreani², C. Bellini³, M. Bombara⁴, S. Brizzi¹, P. Calzoni⁵, M. Casini⁶, F. Cesari⁷, D. Fineschi⁸, A.M.G. Gelli⁹, L. Iordache¹⁰, M. Lorubbio¹¹, M. Martelloni⁹, A. Rogolino⁷, V. Scaccia³, M. Spagnuolo⁴, A. Terrosi³, F. Veneziani¹², R. Marcucci⁷, A.M. Gori⁷ | ¹SOS Patologia Clinica San Jacopo, Pistoia e SS Cosma e Damiano, Pescia, Azienda USL Toscana Centro, Italy; ²S.S.D Analisi Chimico-Cliniche Apuane e Microbiologia molecolare, Osp. delle Apuane, Azienda U.S.L Toscana Nord-Ovest, Italy; ³Lab. Analisi Chimico-Cliniche, Dip. di Medicina Diagnostica, Trasfusionale e Dei Servizi, Osp. Misericordia Grosseto AUSL TSE, Italy; ⁴Azienda USL Toscana Nordovest - Dipartimento Diagnostiche di Laboratorio, U.O.C. Laboratorio Analisi Chimico Cliniche, Ambito Territoriale Livorno, Italy; ⁵UOS Coagulazione, UOC Laboratorio di Patologia Clinica, AOU Senese, Italy; ⁶U.O. Analisi Chimico-Cliniche Azienda Ospedaliero Universitaria Pisana, Italy; ⁷Azienda Ospedaliero Universitaria Careggi, Dipartimento di Medicina Sperimentale e Clinica, Università di Firenze, Italy; ⁸UOC Laboratorio di Patologia Clinica, AOU Senese, Italy; ⁹SOS Patologia Clinica PO San Giuseppe, Empoli, Italy; ¹⁰Laboratorio Di Analisi Chimico-Cliniche E Microbiologiche, Ospedale Santo Stefano, Prato, Italy; ¹¹UOSD Medicina di Laboratorio Valdarno, Azienda USL Toscana Sud Est, Arezzo, Italy; ¹²Laboratorio Patologia Clinica, Ospedale San Giovanni di Dio, Firenze, Italy

  Michela Di Gioia

  26-10-2026

  https://doi.org/10.4081/btvb.2026.801

  0

  PDF: 0

• CO021 | TIME COURSE OF LP(a) LEVELS AFTER ACUTE CORONARY SYNDROME: A LONGITUDINAL STUDY G. Barbieri¹, A.M. Gori¹, G. Ciarrocca Taranta¹, M. Di Gioia¹, F. Alfano¹, E. Lotti¹, A. Rogolino¹, F. Cesari¹, B. Giusti¹, M. Berteotti¹, R. Marcucci¹ | ¹Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence - Careggi Hospital, Firenze, Italy

  Giulia Barbieri

  26-10-2026

  https://doi.org/10.4081/btvb.2026.723

  0

  PDF: 0

• CO078 | METABOLOMIC AND LIPOPROTEOMIC MODULATION FOLLOWING INCLISIRAN TREATMENT IN DYSLIPIDEMIC PATIENTS J. Patrussi¹, A. Vignoli^1|2, L. Tenori^1|2, A. Sorrentino³, M. Berteotti^3|4, E. Lotti⁴, F. Crudele⁴, G. Ciarrocca Taranta³, A.A. Rogolino⁴, G. Barbieri³, A.M. Gori^3|4, R. Marcucci^3|4 | ¹Dep. of Chemistry "Ugo Schiff", University of Florence, Sesto Fiorentino, Italy; ²Magnetic Resonance Center (CERM), University of Florence, Sesto Fiorentino, Italy; ³Dep. of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; ⁴Azienda Ospedaliero-Universitaria Careggi, Firenze, Italy

  Andrea Sorrentino

  26-10-2026

  https://doi.org/10.4081/btvb.2026.780

  0

  PDF: 0